3-Methylcholanthrene/Aryl-Hydrocarbon Receptor-Mediated Hypertension Through eNOS Inactivation.
about
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases.
P2860
3-Methylcholanthrene/Aryl-Hydrocarbon Receptor-Mediated Hypertension Through eNOS Inactivation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@en
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@nl
type
label
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@en
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@nl
prefLabel
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@en
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@nl
P2093
P2860
P356
P1476
3-Methylcholanthrene/Aryl-Hydr ...... ion Through eNOS Inactivation.
@en
P2093
Chih-Cheng Chang
Hsiu-Chu Chou
Shu-Hui Juan
Yuan-Chii G Lee
Yung-Ho Hsu
P2860
P304
P356
10.1002/JCP.25497
P577
2016-07-21T00:00:00Z